radiosensitizer

OBJECTIVE To discuss the inhibitive activity of proteinase of hypoxic cells radiosensitizer .

探讨乏氧细胞放射增敏剂的蛋白酶抑制活性。

Clinical value of tumor radiosensitizer in the radiation therapy of nasopharyngeal carcinoma

肿瘤放射增敏剂在鼻咽癌放射治疗的临床价值

CONCLUSIONS This compound may be a good radiosensitizer .

结论：该化合物极有可能成为一个好的增敏剂。

Recent Advance of Research on Hypoxic Cell Radiosensitizer

乏氧细胞放射增敏剂研究进展

The molecular mechanism of tumor radiosensitizer

肿瘤辐射增敏的分子机制

Primary clinical study of Radiosensitizer CMNa

放疗增敏剂甘氨双唑钠的Ⅱ期临床研究

Radiosensitizer of hypoxic cell with inhibitive action of proteinase

具有蛋白酶抑制作用的乏氧细胞放射增敏剂Tx-1836

These results provide evidence for further investigation of berberine as a new anti-cancer agent and radiosensitizer in therapy of breast cancer .

这些研究结果表明黄连素可以作为乳腺癌新治疗药物，也为黄连素的深入研究提供了实验基础和理论依据。

The Design and Synthesis of 2 nitroimidazoles Compounds as a Hypoxic Cell Radiosensitizer and Their Anti angiogenic Activity

2-硝基咪唑类乏氧细胞放射线增敏剂的合成及其抑制血管增生作用

AIM : To search for more effective and less toxic new type radiosensitizer , three types of organic germanium sesquioxide were synthesized .

目的：为寻找新型低毒有效放射增敏剂，合成了3种类型有机锗倍半氧化物。

The observation of intratumoral injection of radiosensitizer

瘤体内注射辐射增敏剂的研究

Except that the single product of small dose is taken as radiosensitizer , the product is not suitable to be applied together with radiotherapy generally .

除单用本品较小剂量作放射增敏剂外，一般不宜和放射治疗同用。

So the study was supposed to provide experimental foundation that arsenic trioxide as a radiosensitizer could be used for the therapeutic alliance of gastric cancer .

通过此实验，从而为As2O3作为放射增敏剂运用于胃癌的联合治疗提供实验依据。

It is necessary to find an ideal radiosensitizer , which can not only inhibit the growth of colorectal cancer cells but also increase the sensitivity to radiation therapy .

寻找一种理想的放疗增敏剂，既可以抑制肿瘤细胞生长，又能增加肿瘤细胞对放疗的敏感性，成为当前抗肿瘤研究的一个重要方向。

Radiosensitizer is through the application of chemical or biological means to increase tumor cell sensitivity to radiation therapy , but not significant increase in the radiosensitivity of normal tissues .

放射增敏剂是指通过应用化学或生物手段来增加肿瘤细胞对放射治疗的敏感性，但不明显增加正常组织的放射敏感性。

The study of hypoxia imaging agents , which is derived from the application of radiosensitizer in hypoxic tissues , has been a hotspot in the field of radiopharmaceuticals .

应用乏氧组织显像剂探测缺氧、缺血组织已成为国际上放射性新药研究的一个热点，其思路源于对乏氧组织应用放射增敏剂。

People take different measures to control the resisting to hypoxic cell in the therapy up to now , including adding radiosensitizer , using bioreductive agents , microwave therapy and so on .

目前为克服肿瘤低氧细胞对治疗的抗拒性，采取了许多不同的方法，包括加增敏剂、用生物还原剂、微波治疗等。

The use of radiosensitizer can reduce radiotherapy dose effectively and enhance radiosensitivity of tumor cells . Therefore it can increase effectiveness of radiotherapy and lower injury to normal tissues and organs .

放射增敏剂的应用可以有效地降低放射剂量，增加肿瘤细胞对辐射的敏感性，从而提高放疗的疗效，减少肿瘤周围正常组织和器官的损伤。

Objective : To investigate the role of specific protein kinase C ( PKC ) inhibitor chelerythrine ( CH ) as radiosensitizer in combination with low-dose irradiation in the induction of Panc-1 apoptosis .

目的：探讨特异性蛋白激酶C（PKC）抑制剂白屈菜红碱（CH）与小剂量照射联合应用对Panc-1细胞凋亡的作用。

Conclusion : CMNa used as a radiosensitizer in 3 times weekly dose of 800mg · m-2 given by intravenous injection for 6 consecutive weeks is tolerable and this regimen is recommended to be used in phase ⅱ clinical trial .

结论：每周3次（隔日）连续6周静脉滴注甘氨双唑钠（800mg·m-2）是可以耐受的，推荐为Ⅱ期临床试验剂量。